GOSS Gossamer Bio Inc Net earnings per share growth forecast for next year
Gossamer Bio, Inc. (GOSS) maintains a high reputation for developing serological treatments for immune pathologies. The company's EPS projections for the coming year reflect current trends, with the indicator standing at 59.90. While the business focuses on developing innovative drugs for pulmonary hypertension, the lack of commercialized products deprives the company of pricing power, leaving it dependent on external financing.
Metric breakdowns and analytics for gossamerbio.com (GOSS)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
- earnings and valuation multiples information:
GOSS - Net Income|Projected Future Earnings Gossamer Bio, Inc.|GOSS - Market Cap to Earnings|Future Price to Earnings Gossamer Bio, Inc.|GOSS - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio Gossamer Bio|GOSS - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Gossamer Bio|GOSS - Earnings per share for the last twelve months|Quarterly EPS earnings growth gossamerbio.com|GOSS - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Gossamer Bio, Inc.
Initial company analysis:GOSS, Gossamer Corp
Investors assess capital risks by analyzing consensus forecasts, where deviations of actual results from expectations trigger sharp asset revaluations. For Gossamer Bio, Inc. (GOSS), whose resilience is supported by partnerships in the development of pulmonary hypertension drugs, the forward net income trend reflects the dynamics of future earnings per share, allowing for a comparison of profit growth rates with the long-term stability of free cash flow.
Competitor analysis
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|Kiniksa Pharmaceuticals Ltd - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Grifols Biemat (GRFS)|Adaptive Biotechnologies (ADPT) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year celldex.com (CLDX)|Net earnings per share growth forecast for next year Aurinia Pharmaceuticals Inc.|BioCryst Pharmaceuticals, Inc. (BCRX) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Vera Pharma (VERA)|Consensus forecast of earnings per share growth for next year Dianthus Corp|Earnings growth forecast for next year PHVS (Pharvaris N.V.)|Earnings growth forecast for next year abcellera.com ABCL|TRML - Net earnings per share growth forecast for next year|Precigen Inc (PGEN) - Expected earnings per share growth for next year|PHAR: Earnings growth forecast for next year|Expected net earnings per share growth next year Nektar Corp (NKTR)|Net earnings per share growth forecast for next year Upstream Bio Inc|ZBIO: Expected earnings per share trend next year|Expected earnings per share growth for next year IMNM (Immunome)|KALV (KalVista Pharma) - Expected earnings per share trend next year|Earnings growth forecast for next year SEPN (Septerna Corp)|Pieris Corp - Net earnings per share growth forecast for next year|Savara Inc. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year rigel.com RIGL|AnaptysBio (ANAB) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Astria Therapeutics Inc (ATXS)|Expected earnings per share growth for next year ENGN|RAPT: Expected earnings per share trend next year|Earnings growth forecast for next year JBIO|Consensus forecast of earnings per share growth for next year aclaristx.com|Net earnings per share growth forecast for next year Kyverna Therapeutics, Inc. KYTX|TLSA: Projected earnings per share growth rate for next year|Cabaletta Bio, Inc - Earnings growth forecast for next year|Ventyx Biosciences, Inc (VTYX) - Expected earnings per share growth for next year|THTX (Theratechnologies Inc.) - Expected earnings per share growth for next year|AVTX - Consensus forecast of earnings per share growth for next year|ELDN (Eledon Pharmaceuticals, Inc.) - Earnings growth forecast for next year|AGEN - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year Climb Bio, Inc. (CLYM)|ZURA - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year aTyr Pharma, Inc. ATYR|Consensus forecast of earnings per share growth for next year Adagene Inc (ADAG)|IMA - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Shattuck Labs, Inc. STTK|equilliumbio.com (EQ) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year CNTB (Connect Biopharma Holdings Limited)|IMUX (Immunic Therapeutics) - Earnings growth forecast for next year|ATRA: Expected earnings per share trend next year|Earnings growth forecast for next year IFRX|Earnings growth forecast for next year X4 Pharmaceuticals Inc. (XFOR)|Net earnings per share growth forecast for next year Adicet Bio, Inc. ACET|Expected earnings per share trend next year CELU|INMB - Net earnings per share growth forecast for next year|barinthusbio.com (BRNS) - Expected earnings per share growth for next year|KZR: Earnings growth forecast for next year|SAB Biotherapeutics Inc. (SABS) - Earnings growth forecast for next year|Expected earnings per share growth for next year AKTX|ENLV: Expected earnings per share trend next year|Earnings growth forecast for next year QTTB|Consensus forecast of earnings per share growth for next year geovax.com|Net earnings per share growth forecast for next year Edesa Biotech EDSA|IBIO - Expected earnings per share growth for next year|CARM - Net earnings per share growth forecast for next year|XTL Bio (XTLB) - Expected earnings per share growth for next year|BOLT (boltbio.com) - Expected earnings per share growth for next year|HCW Biologics (HCWB) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Aptevo Therapeutics, Inc.|Projected earnings per share growth rate for next year AIM (AIM ImmunoTech, Inc.)|Earnings growth forecast for next year ADTX|GRI - Expected net earnings per share growth next year|Earnings growth forecast for next year XRTX (XORTX Therapeutics Inc.)|Net earnings per one share growth forecast for next year reshapelifesciences.com|REVB - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Indaptus Therapeutics Inc|Scinai (SCNI) - Net earnings per share growth forecast for next year|CALI - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Affimed NV|Allakos Therapeutics (ALLK) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year HOOK|Earnings growth forecast for next year igmbio.com (IGMS)|Net earnings per share growth forecast for next year iTeos ITOS|OCEA - Expected earnings per share growth for next year|TC Biopharm - Earnings growth forecast for next year|Expected net earnings per share growth next year thirdharmonicbio.com
